Brief: Kang Stem Biotech receives patent
27/08/2018 03:14
Aug 27 (Reuters) - Kang Stem Biotech Co Ltd 217730.KQ :
* Says it receives patent named Isolating Method for
Umbilical
Cord Blood-Derived Pluripotent Stem Cells Expressing ZNF281
Source text in Korean: https://goo.gl/Q9qcRr
Further company coverage: 217730.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; Reuters Messaging:
Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on Kang Stem Biotech
See all newsBrief: Kangstem Biotech To Conduct Capital Increase Of 49 Billion Won
Brief: Kangstem Biotech To Conduct Capital Increase Of 35.7 Billion Won
Brief: Kang Stem Biotech to invest 8.76 bln won in facilities extension
Brief: Kang Stem Biotech receives patent
Brief: Kang Stem Biotech raises 35.95 bln won via rights issue